ICYMI, some of this week’s featured content includes articles on the oral, narrow-spectrum antibiotics for acne, the best practices for atopic dermatitis care, oxytocin and its effect on skin aging, plus more.
POLL: Do you listen to dermatology podcasts?
The Mainstream Patient: February 22, 2021
This week’s edition of The Mainstream Patient features stories on psoriatic arthritis medication, “slugging” to treat cystic acne, chemical peels for darker skin types, plus more.
Oral Antibiotics for the Treatment of Acne
Watch one expert detail the benefits and limitations when using oral antibiotics for the treatment of acne.
Narrow Spectrum Antibiotics for Acne
In this video interview with Dermatology Times, one expert discusses how narrow-spectrum antibiotics can both protect the skin and gut microbiome, as well as effectively treat acne.
Topical Actinic Keratosis Treatment Launched in US
Almirall announces the launch of tirbanibulin (Klisyri), a novel microtubule inhibitor for the topical treatment of actinic keratosis on the face or scalp.
Racial Differences for Preferred Acne Care
Factoring in a patient’s genetic heritage when choosing an acne care regimen could improve adherence, according to survey results that identify race-related differences in preferred sources of information and treatments for acne.
Investigators Take Global Look at Best-Practice AD Care
Several universal gaps in diagnosis and treatment of atopic dermatitis (AD) as well as real-world interventions for improvement are the focus of a ground-breaking report.
New Treatments Aim to Increase Survival Rate
Cancer staging systems for squamous cell carcinoma have helped improve dermatologists’ ability to accurately stage the cancer, according to on expert.
Clinical Study Points to Oxytocin’s Antiaging Benefits
Patients with high oxytocin levels had significantly lower (more youthful-looking) skin age scores than expected, even with strong histories of lifetime sun exposure, according to a recent study.
Novel Therapeutics Usher in a Year of Innovation
Pre- and postmarketing psoriasis studies support novel drug results and new labeling.